2024-11-18 10:53:11
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031
Corporate/ 2023-07-24
Antengene Announces Clearance of U.S. IN...

- ATG-031, discovered and developed in-house by Antengene,is the world\'s first anti-CD24 antibody to advance to the clinic in oncology and ...

Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031
Corporate/ 2023-07-24
Antengene Announces Clearance of U.S. IN...

ATG-031, discovered and developed in-house by Antengene,is the world\'s first anti-CD24 antibody to advance to the clinic in oncology and An...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release